Dr. Hofman on the potential of LuPSMA in advanced prostate cancer
November 11th 2021“We expect an outcome from the FDA next year and if that's positive, we expect global, widespread availability of this as a new option for men with metastatic castration-resistant prostate cancer,” says Michael S. Hofman, MBBS (Hons), FRACP, FAANMS, FICIS.
The ENGAGEMENT study and virtual genetics board
November 11th 2021“There really are many considerations regarding germline testing, results interpretation, implications for treatment or screening, and the familial hereditary implications of this whole field. Because of that, understanding the role of genetic counseling is critical, and also understanding the interplay with various somatic testing approaches is also really important,” says Veda N. Giri, MD.
Expert explains latest findings with oral softgel capsule for testosterone replacement therapy
November 11th 2021"We didn't see any clinically significant changes on the prostate gland, which is very important for the urologists who see people who have prostate cancer or prostate enlargement," says Ronald Swerdloff, MD.
Study investigates management strategies for intermediate to high-risk prostate cancer
November 11th 2021“We [at GenesisCare] would be really interested in looking at strategies to identify men that we think are aggressive but localized and offer them a chance to do a shorter course hormonal therapy, which is going to substantially improve quality of life without losing on the efficacy end,” says Bridget F. Koontz, MD.
Outcomes show high rates of penile curvature improvement after CCH injections
November 10th 2021“Both [IMPRESS trials] would suggest that if patients are motivated to see if they can continue to improve their curvature and avoid things like surgery—which for many patients…is a goal—continuing with the collagenase makes good sense,” says Matthew J. Ziegelmann, MD.
Destigmatizing Urology: Dr. Nickel discusses recurrent UTIs in women
November 10th 2021“[Promoting anti-microbial resistance is] really the only stigma and it's not the fault of the patients with recurrent urinary tract infection…most of us in the medical profession realize that this stigma is more the result of our only treatment we have for this condition,” says J. Curtis Nickel, MD, FRCSC.
Researchers investigate association between gut microbiome and aggressive prostate cancer
November 8th 2021“There's been a lot of evidence over the past few years that there's certainly a…correlation between dietary intake and risk of prostate cancer, [but] there's really not a whole lot of data on risk of development of lethal prostate cancer,” says Nima Sharifi, MD.
Advantages of Aquablation for patients and urologists
November 8th 2021“There are a number of significant advantages of this new technology, including the maintenance of antegrade ejaculation, the short operative time [and] the exceptional outcomes postoperatively for the patient,” says Naeem Bhojani, MD, FRCSC.
Dr. Koontz on study of dose-escalated RT plus androgen suppression in prostate cancer
November 6th 2021“The RTOG-0815 study [of dose-escalated RT plus androgen suppression] has provided...data to have an intelligent conversation with our patients and provide them numbers so that they know what to expect,” says Bridget F. Koontz, MD.
Rezum reduces lower urinary tract symptoms in men with BPH
November 4th 2021"If you look at men who had sexual dysfunction at the beginning of the study, compared to men that had good sexual function at the beginning of a study, both groups of men have equal response to improvement in their lower urinary tract symptoms,” says Kevin T. McVary, MD, FACS.
Dr. Stacy Loeb urges urologists to take “dramatic action for climate change”
November 2nd 2021“I would encourage other people to think about their own routines in the operating room, in the clinic, going to conferences, hosting conferences, doing interviews, and where each one of us could even slightly cut back,” says Stacy Loeb, MD, PhD, MSc.
Expert discusses studies of Optilume drug-coated balloon for urethral strictures
November 2nd 2021“What our studies were looking at was a novel device that could potentially help bridge the gap between [endoscopic treatment and urethroplasty] to achieve endoscopic treatment and achieve greater success,” says Justin Chee, MD.
Penile curvature improvement in Peyronie's disease assessed in post hoc analysis of IMPRESS trials
October 29th 2021“The goal of this study was to look at that original phase 3 trial data [from 2013] and see if we could identify how much change in curvature patients were achieving with each of those 2 injections,” says Matthew J. Ziegelmann, MD.